Your request to link to rcsb for Stromelysin-1

• 1E9Y: crystal structure of helicobacter pylori urease in complex with acetohydroxamic acid (10.1038/88563 )
• 6OVH: cryo-em structure of bimetallic dodecameric cage design 3 (bmc3) from cytochrome cb562 (10.1038/S41586-019-1928-2 )
• 3LJG: human mmp12 in complex with non-zinc chelating inhibitor (10.1074/JBC.M110.139634 )
• 1Y93: crystal structure of the catalytic domain of human mmp12 complexed with acetohydroxamic acid at atomic resolution (10.1073/PNAS.0407106102 )
• 1OS2: ternary enzyme-product-inhibitor complexes of human mmp12 (10.1002/ANIE.200350957 )
• 3BA0: crystal structure of full-length human mmp-12 (10.1021/JA710491Y )
• 2OZR: mmp13 catalytic domain complexed with 4-{[1-methyl-2,4-dioxo-6-(3- phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2h)-yl]methyl}benzoic acid (10.1074/JBC.M703286200 )
• 4H9M: the first jack bean urease (canavalia ensiformis) complex obtained at 1.52 resolution
• 3LKA: catalytic domain of human mmp-12 complexed with hydroxamic acid and paramethoxy-sulfonyl amide (10.1021/JM901723Z )
• 3DPF: crystal structure of the complex between mmp-8 and a non-zinc chelating inhibitor (10.1021/JM801166J )
• 1UTT: crystal structure of mmp-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2h- isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid (10.1016/J.JMB.2004.06.039 )
• 1UTZ: crystal structure of mmp-12 complexed to (2r)-3-({[4-[(pyridin-4-yl) phenyl]-thien-2-yl}carboxamido)(phenyl)propanoic acid (10.1016/J.JMB.2004.06.039 )
• 6RD0: human mmp12 catalytic domain in complex with ap280 (10.1016/J.BMC.2019.115177 )
• 5N5J: human mmp12 in complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido) propane-1-sulfonate (10.1021/ACS.JMEDCHEM.7B01237 )
• 5N5K: human catalytic mmp-12 in complex with 5-(1,2-dithiolan-3-yl)-n-(3- hydroxypropyl)pentanamide (10.1021/ACS.JMEDCHEM.7B01237 )
• 1AM6: carbonic anhydrase ii inhibitor: acetohydroxamate
• 2OW9: crystal structure analysis of the mmp13 catalytic domain in complex with specific inhibitor (10.1074/JBC.M703286200 )
• 3KEC: crystal structure of human mmp-13 complexed with a phenyl-2h-tetrazole compound (10.1016/J.BMCL.2009.11.081 )
• 4UBP: structure of bacillus pasteurii urease inhibited with acetohydroxamic acid at 1.55 a resolution (10.1007/S007750050014 )
• 6RLY: human mmp12 (catalytic domain) in complex with ap316 (10.1016/J.BMC.2019.115177 )
• 6OT9: bimetallic dodecameric cage design 1 (bmc1) from cytochrome cb562 (10.1038/S41586-019-1928-2 )
• 6OT8: bimetallic hexameric cage design 4 (bmc4) from cytochrome cb562 (10.1038/S41586-019-1928-2 )
• 6OT4: bimetallic dodecameric cage design 2 (bmc2) from cytochrome cb562 (10.1038/S41586-019-1928-2 )
• 6OT7: bimetallic dodecameric cage design 3 (bmc3) from cytochrome cb562 (10.1038/S41586-019-1928-2 )
• 3LIL: human mmp12 in complex with non-zinc chelating inhibitor (10.1074/JBC.M110.139634 )
• 3LIK: human mmp12 in complex with non-zinc chelating inhibitor (10.1074/JBC.M110.139634 )
• 4A7B: mmp13 in complex with a novel selective non zinc binding inhibitor cmpd22 (10.1016/J.BMCL.2011.11.034 )
• 1FWE: klebsiella aerogenes urease, c319a variant with acetohydroxamic acid (aha) bound (10.1021/BI970514J )
• 2HU6: crystal structure of human mmp-12 in complex with acetohydroxamic acid and a bicyclic inhibitor (10.1016/J.BMC.2006.07.028 )